Philmans Pharm, Cenedella.de, The German Patient Roundtable

Est. 1977

Texas Hemp Industries Association Clarifies Legality Of Hemp Derived CBD Oil

 

http://www.prnewswire.com/news-releases/texas-hemp-industries-association-clarifies-legality-of-hemp-derived-cbd-oil-300328988.html

AUSTIN, Texas, Sept. 15, 2016 /PRNewswire/ — On September 7, the Texas Hemp Industries Association (TXHIA) received notice that the Texas Department of Public Safety (DPS) arrived at People’s Pharmacy’s four (4) Austin locations to confiscate various industrial hemp Cannabidiol (CBD) products.  It is the position of the TXHIA that CBD products legally produced under the Federal 2014 Farm Bill are lawful for sale.

Background:  In 2015, the Texas Legislature passed SB 339, Compassionate Use Act to allow intractable epileptics access to medical cannabis for distribution under physician oversight.  This law was reported by the media as the “low THC, high CBD bill“. Sheila Hemphill, TXHIA Policy Director surmised, “we believe the media terminology may have created confusion with various law enforcement departments by giving the false impression that CBD only comes from a medicinal cannabis plant and would be subject to DPS regulations.  We appreciate DPS’s diligence to insure product and public safety.  This investigation will bring much needed clarity to the public regarding the legality of industrial hemp CBD products containing 0.3% or less THC.  We are optimistic for a good outcome for all parties.”

About CBD:  Industrial hemp is from a variety of the Cannabis Sativa L plant with concentration levels of delta 9 Tetrahydrocannabinol (THC) of 0.3% or less as defined by the 2014 Federal Farm Bill.  Within the Cannabis Sativa L plant are molecules known as cannabinoids.  All mammals have an endocannabinoid system that is nourished from cannabinoids.  Non-cannabis plants that contain cannabinoids include:  Chocolate- Theobroma cacao, Black pepper- Piper nigrum, Coneflower –Echinacea and others.  Humans naturally produce the cannabinoids Anandamide and 2-Arachidonoylglycerol (2-AG).

Delta 9 Tetrahydrocannabinol (THC) is the only cannabinoid that creates a psychoactive effect.  In the raw plant state, the THC molecule is confined within a different non-psychoactive cannabinoid known as THCA.  Cannabidiol (CBD) is a non-psychoactive cannabinoid found in the industrial hemp plant and has been reported to have anti-inflammatory, anti-anxiety, and anti-seizure properties.

Cannabidiol derived from a legal industrial hemp plant is an essential oil, like lavender or peppermint, and is not subject to the regulation established by the Texas Compassionate Use Act.   This Act created a medical cannabis program that permits THC levels higher than the 0.3% threshold allowed for industrial hemp products. As a medical cannabis program, the Compassionate Use Act increases the THC threshold to 0.5%, and requires that CBD content be “not less than 10% by weight of cannabidiol”.  This clause is the only reference to CBD in Texas State or Federal law.

Since the DPS investigation is analyzing industrial hemp products, the TXHIA is acting as liaison between the retailers and industrial hemp vendors and DPS.  TXHIA is in close contact with DPS as they conduct their investigation into the confiscated products.  At this time, there is not a clear time frame for when DPS will conclude their investigation.  All media inquiries should be directed to the TXHIA.

“Industrial hemp products are safe, legal and can be purchased on-line or on the shelves of hundreds of retail locations in Texas.  Thousands of Texans have purchased and benefited from the use of industrial hemp products such as hemp hearts, protein, milk, cosmetics, and CBD oil,” asserts Coleman Hemphill, TXHIA Executive Director.

About: The Texas Hemp Industries Association is a 501(c) 6 state chapter of the Hemp Industries Association.

Media Contact: 

Sheila Hemphill, Policy Director, TXHIA              

325.226.3683  |  Sheila@txhia.org

Lauren Stansbury, Director of Media Relations, HIA   

402.540.1208  |  Lauren@votehemp.com

Author: Cenedella.de

Over the last 4 decades I have been involved in the fight for patient rights in America, and now here in Germany. During my career I have served as a Board of Director for the World Trade Center San Diego and as a Lead Consultant for Deutsche Telekom's Executive Board, Co-Founded the San Diego Software Council and the Dayton Human Trafficking Accords and was Director of LawInfo's Lead Council Program. Previously I was a C-Level Business Development Executive in the technology sector, but also involved with the cannabis industry since 1977. More recently I have been fulltime in the legal medical marijuana industry here in Europe, helping international companies navigate the biggest potential market in the world. This website is light on details due to confidentiality issues with clients but be rest assured I am knowledgeable, professional and with street cred in the industry that can immediately assist your growth in some way. Consulting Services: Sales and Business Development Assist with Strategic Direction Professionally represent your firm Special Projects management Licensing and compliance Sales and Distribution networks Qualify potential partners I am your resource on the ground in Europe, contact me directly to schedule an initial discussion on the German Cannabis-as-Medicine market. Thank you, Philip J. Cenedella IV Call +1.888.206.3264 USA +49.0.151.720.17652 GERMANY Skype: philip.j.cenedella eMail: phil@cenedella.de LinkedIN: https://www.linkedin.com/in/cenedellade/

Comments are closed.